The Netherlands’ largest ambulatory clinic chain announced a 60:40 merger with the second largest yesterday (September 26) creating a group that dominates hip and knee ops, and is aiming for €500m in sales within three years. We speak to Bergman CEO Bart Malenstein and a local advisor.



